Pathophysiology of acne

Dermatologic Therapy

Volumn 6, Issue , 1998, Pages 7-17

  Jansen, Thomas ^b   Plewig, Gerd ^b   Kligman, Albert Montgomery ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; GENETIC RISK; HORMONAL REGULATION; HUMAN; KERATINIZATION; PATHOPHYSIOLOGY; REVIEW; SEBACEOUS GLAND;

EID: 0031789707     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Cunliffe WJ, Clayden D, Gould DJ, Simpson NB. Acne vulgaris - its aetiology and treatment: a review. Clin Exp Dermatol 1981: 6: 461-469.
2. Leyden JJ. New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995: 32: S15-25.
3. Plewig G, Kligman AM. Acne and rosacea. 2nd edn. Berlin: Springer, 1993.
4. Pochi PE. The pathogenesis and treatment of acne. Annu Rev Med 1990: 41: 187-198.
5. Voorhees JJ, Wilkins JW Jr, Hayes E, Harrell ER. Nodulocystic acne as a phenotypic feature of the XYY geno-type: report of five cases, review of all known XYY subjects with severe acne, and discussion of XYY cytodiagnosis. Arch Dermatol 1972: 105: 913-919.
6. Damon A. Constitutional factors in acne vulgaris. Arch Dermatol 1957: 76: 172-178.
7. Hinrichsen J, Ivy AC. Incidence in the Chicago region of acne vulgaris. Arch Dermatol Syph 1938: 37: 975-982.
8. Walton S, Wyatt E, Cunliffe WJ. Genetic control of sebum excretion and acne: a twin study. Br J Dermatol 1988: 118: 393-396.
9. Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 1974: 62: 288-307.
10. Lynch FW. Acne vulgaris: review of histologic changes observed in early lesions. Arch Dermatol Syph 1940: 42: 593-606.
11. Norris JFB, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988: 118: 651-659.
12. Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol 1960: 82: 779-790.
13. Cunliffe WJ, Shuster S. Pathogenesis of acne. Lancet 1969: I: 685-687.
14. Harris HH, Downing DT, Stewart ME, Strauss JS. Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol 1983: 8: 200-203.
15. Pochi PE, Strauss JS. Sebum production, casual sebum levels, titratable acidity of sebum, and urinary fractional 17-ketosteroid excretion in males with acne. J Invest Dermatol 1964: 43: 383-388.
16. Powell EW, Beveridge GW. Sebum excretion and sebum composition in adolescent men with and without acne vulgaris. Br J Dermatol 1970: 82: 243-249.
17. Strauss JS, Pochi PE, Downing DT. Acne: perspectives. J Invest Dermatol 1974: 62: 321-325.
18. Morello AM, Downing DT, Strauss JS. Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol 1976: 66: 319-323.
19. Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol 1986: 14: 221-225.
20. Melnik B, Plewig G. Neue lipidbiochemische Aspekte in der Pathogenese der follikulären Verhornungsstörung bei Acne vulgaris. Z Hautkr 1988: 63: 591-596.
21. McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1978: 12: 672-675.
22. Rebello T, Hawk JLM. Skin surface glycerol levels in acne vulgaris. J Invest Dermatol 1978: 70: 352-354.
23. Kligman AM, Wheatley VR, Mills OH Jr. Comedogenicity of human sebum. Arch Dermatol 1970: 102: 267-275.
24. 16. Arch Dermatol 1968: 97: 722-726.
25. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983: 109: 191-198.
26. Saint-Leger D, Bague A, Cohen E, Chivot M. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br J Dermatol 1986: 114: 535-542.
27. Hassing GS. Inhibition of Corynebacterium acnes lipase by tetracycline. J Invest Dermatol 1971: 56: 189-192.
28. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilosebaceous units from human skin. J Gen Microbiol 1984: 130: 803-807.
29. Leeming JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of micro-organisms colonising acne vulgaris comedones. J Med Microbiol 1985: 20: 11-16.
30. Leeming JP, Holland KT, Cunliffe WJ. The microbial colonisation of inflamed acne vulgaris lesions. Br J Dermatol 1988: 118: 205-208.
31. Marples RR, Leyden JJ, Stewart RN, Mills OH Jr, Kligman AM. The skin microflora in acne vulgaris. J Invest Dermatol 1974: 62: 37-41.
32. Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971: 103: 148-153.
33. Cornelius CE, Ludwig GD. Red fluorescence of comedones: production of porphyrins by Corynebacterium acnes. J Invest Dermatol 1967: 49: 368-370.
34. Sauermann G, Ebens B, Hoppe U. Analysis of facial comedos by porphyrin fluorescence and image analysis. J Toxicol Cutan & Ocular Toxicol 1989/90: 9: 369-385.
35. Leyden JJ, McGinley KJ, Mills OH Jr, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975: 65: 382-384.
36. Bläuer M, Vaalasti A, Pauli SL, Ylikomi T, Joensuu T, Tuohimaa P. Location of androgen receptor in human skin. J Invest Dermatol 1991: 97: 264-268.
37. Bonne C, Saurat JH, Chivot M, Lehuchet D, Raynaud JP. Androgen receptor in human skin. Br J Dermatol 1977: 97: 501-503.
38. Lucky AW. Endocrine aspects of acne. Pediatr Clin North Am 1983: 30: 495-499.
39. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995: 105: 209-214.
40. Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol 1989: 125: 571-572.
41. Mayerhausen W, Riebel B. Acne fulminans nach Anabolikaeinnahme. Z Hautkr 1989: 64: 875-880.
42. Pye RJ, Meyrick G, Pye MJ, Burton JL. Effect of oral contraceptives on sebum excretion rate. Br Med J 1977: II: 1581-1582.
43. Strauss JS, Kligman AM. The effect of progesterone and progesterone-like compounds on the human sebaceous gland. J Invest Dermatol 1961: 36: 309-319.
44. Miller JA, Wojnarowska FT, Dowd PM et al. Anti-androgen treatment in women with acne: a controlled trial. Br J Dermatol 1986: 114: 705-716.
45. Sperling LC, Heimer WL II. Androgen biology as a basic for the diagnosis and treatment of androgenic disorders in women. I. J Am Acad Dermatol 1993: 28: 669-683.
46. Sperling LC, Heimer WL II. Androgen biology as a basic for the diagnosis and treatment of androgenic disorders in women. II. J Am Acad Dermatol 1993: 28: 901-916.
47. Lucky AW, McGuire J, Rosenfield RL, Lucky PA, Rich BH. Plasma androgens in women with acne. J Invest Dermatol 1983: 81: 70-74.
48. Darley CR, Moore JW, Besser GM et al. Androgen status in women with late onset or persistent acne vulgaris. Clin Exp Dermatol 1984: 9: 28-35.
49. Lawerence D, Shaw M, Katz M. Elevated free testosterone concentration in men and women with acne vulgaris. Clin Exp Dermatol 1986: 11: 263-273.
50. Lookingbill DP, Horton R, Demers LM, Egan N, Marks JG Jr, Santen RJ. Tissue production of androgens in women with acne. J Am Acad Dermatol 1985: 12: 481-487.
51. Sansone G, Reisner RM. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin - a possible pathogenic factor in acne. J Invest Dermatol 1971: 56: 366-372.
52. Held BL, Nader S, Rodriguez-Rigau LJ, Smith KD, Steinberger E. Acne and hyperandrogenism. J Am Acad Dermatol 1984: 10: 223-226.
53. Walton S, Cunliffe WJ, Keczkes K, Early AS, Garrigle HHG, Katz M, Reese RA. Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris. Br J Dermatol 1995: 133: 249-253.
54. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989: 30: 459-470.
55. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989: 31: 87-120.
56. Zander J, Mickan H, Holzmann K, Lohe KJ. Androluteoma syndrome of pregnancy. Am J Obstet Gynecol 1978: 130: 170-177.
57. Derksen J, Nagesser SK, Meinders AE, Haak HR, Van de Velde JH. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994: 331: 968-973.
58. Rose LI, Newmark SR, Strauss JS, Pochi PE. Adrenocortical hydroxylase deficiencies in acne vulgaris. J Invest Dermatol 1976: 66: 324-326.
59. Pekkarinen A, Sonck CE. Adrenocortical reserves in acne vulgaris: the urinary excretion of 17-ketosteroids and total 17-hydroxycorticosteroids. Acta Derm Venereol (Stockh) 1962: 42: 200-210.
60. Plewig G. Follicular keratinization. J Invest Dermatol 1974: 62: 308-315.
61. Holmes RL, Williams M, Cunliffe WJ. Pilo-sebaceous duct obstruction and acne. Br J Dermatol 1972: 87: 327-332.
62. Knaggs HE, Hughes BR, Morris C, Wood EJ, Holland DB, Cunliffe WJ. Immunohistochemical study of desmosomes in acne vulgaris. Br J Dermatol 1994: 130: 731-737.
63. Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971: 242: 12-29.
64. Lavker RM, Leyden JJ. Lamellar inclusions in follicular horny cells: a new aspect of abnormal keratinization. J Ultrastruct Res 1979: 69: 362-370.
65. Kanaar P. Follicular-keratogenic properties of fatty acids in the external ear canal of the rabbit. Dermatologica 1971: 142: 14-22.
66. Lavker RM, Leyden JJ, McGinley KJ. The relationship between bacteria and the abnormal follicular keratinization in acne vulgaris. J Invest Dermatol 1981: 77: 325-330.
67. Van Scott EJ, MacCardle RC. Keratinization of the duct of the sebaceous gland and growth cycle of the hair follicle in the histogenesis of acne in human skin. J Invest Dermatol 1956: 27: 405-429.
68. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995: 33: 247-253.
69. Ingham E, Gowland G, Ward RM, Holland KT, Cunliffe WJ. Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris. Br J Dermatol 1987: 116: 805-812.
70. Puhvel SM, Barfatani M, Warnick M, Sternberg TH. Study of antibody levels to Corynebacterium acnes. Arch Dermatol 1964: 90: 421-427.
71. Puhvel SM, Hoffman IK, Sternberg TH. Corynebacterium acnes: presence of complement fixing antibodies to Corynebacterium acnes in the sera of patients with acne vulgaris. Arch Dermatol 1966: 93: 364-366.
72. Palatsi R. Delayed hypersensitivity and febrile acne conglobata. Acta Derm Venereol (Stockh) 1977: 57: 51-53.
73. Rajka G. Delayed reactivity to bacterial and viral extracts in different dermatoses. Acta Derm Venereol (Stockh) 1970: 50: 281-286.
74. Puhvel SM, Sakamoto M. The chemoattractant properties of comedonal components. J Invest Dermatol 1978: 71: 324-329.
75. Webster GF, Leyden JJ. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980: 4: 261-269.
76. Kabongo Muamba ML. Exoenzymes of Propionibacterium acnes. Can J Microbiol 1982: 28: 758-761.
77. Webster GF, Tsai CC, Leyden JJ. Neutrophil lysosomal release in response to Propionibacterium acnes. J Invest Dermatol 1979: 72: 209 (abstract).
78. Webster GF, Leyden JJ, Norman ME, Nilsson UR. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 1978: 22: 523-529.
79. Webster GF, McArthur WP. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate. J Invest Dermatol 1982: 79: 137-140.
80. Tucker SB, Rogers RS III, Winkelmann RK, Privett OS, Jordon RE. Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol 1980: 74: 21-25.
81. Strauss JS, Pochi PE. Intracutaneous injection of sebum and comedones: histological observations. Arch Dermatol 1965: 92: 443-456.